Bright! FRONTEO Official Blog

Bright! FRONTEO Official Blog

[Webinar held on March 3] Automatic document sorting AI system "Mekiki" -Introduction of 9 use cases-

"Mekiki" is a system that automatically searches, scores, and sorts medical and medical specialized information using the artificial intelligence engine "Concept Encoder" developed by FRONTEO for the life science field.

In pharmaceutical companies, we handle specialized medical information based on strict standards in operations such as clinical development, pharmaceutical application, and quality control, and supervise and guide promotion activities in accordance with the "Guidelines for sales information provision of ethical drugs." A lot of effort and cost is spent on document management and examination work.
Improve operational efficiency by automatically detecting, classifying, and reviewing highly specialized information, such as disease information, drug safety information, competitive product information, sales and public relations documents, etc. We will introduce a use case of "Mekiki" that realizes.

Click here for registration and seminar details:https://lifescience.fronteo.com/webinar20230309
 

【Webinar Summary】

◆ Theme: Automatic document sorting AI system “Mekiki” ~Introduction of XNUMX use cases~

Date: March 2023, 3 (Thursday) 9:12-10:12

◆ Recommended for people like this!
・ Those who work for a pharmaceutical company
・Those who have problems with document management work
・Those who are worried about document monitoring such as daily reports and emails
・ Those who want to improve work efficiency by utilizing AI

◆Participation conditions: Those who use the free address, those who are in the same industry as our company, and those whose affiliation is unknown are not allowed to apply.When accessing ZOOM on the day, please enter the name and email address you entered at the time of application in the ZOOM participation entry field.
 

 
Speakers
 
 
FRONTEO Inc.
Life Science AI Business Headquarters Medical DX Team
Yuko Koda

After joining a foreign pharmaceutical company in 2002, he worked as a sales representative (MR).He is in charge of everything from university hospitals to clinics, mainly in the fields of cardiovascular medicine, collagen disease internal medicine, and aesthetic medicine.After that, he joined FRONTEO Co., Ltd. in 2023 after working as a consultant for clinics and a sales manager. He is involved in proposing solutions using AI.

Articles in the same category

[Real Seminar on June 6th] Initial Response and Legal Actions in Case of Trade Secret Leakage ~Collaboration between Departments and Digital Forensics~

[June 6nd Webinar] How Japanese Companies Gain an Advantage in US Lawsuits. -How to reduce the advantages and disadvantages unique to Japanese companies- 

[6/8 Webinar] Latest US Department of Justice (DOJ) corporate crackdown policy and its impact on Japanese companies

[Webinar held on June 6] Comparative study of what companies are required to do regarding business and human rights and the actual efforts of each company -Aiming for further respect for human rights and improvement of corporate value-

[Held on May 5th!25nd Economic Security Study Group] "New Phase of M&A for Japan and China Money, Detailed Explanation with Actual Cases" The whole story of how a Chinese entrepreneur who escaped from the Xi Jinping regime set up a takeover in Japan

[Event held on May 5] "Initial response and legal measures in the event of trade secret leaks" by retirees taking out information ~Interdepartmental collaboration and digital forensics~

[May 5th Webinar] Introduction of utilization cases of disease network analysis by natural language processing AI

[May 5th Webinar] Protecting Japanese Companies from U.S. Regulators -- "Best Measures" and "Latest Trends"

[5/23 5th Fraud Countermeasures Study Group] Hypotheses and countermeasures based on the ranking of "100 companies with a large number of whistleblowing cases" Fraud risks that cannot be measured only by the number of whistleblowing reports Former editor-in-chief of Toyo Keizai "CSR Company Directory" Detailed explanation

Commonly viewed articles